Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Coronary Clot Aspiration Provides No MI Survival Benefit

By HospiMedica International staff writers
Posted on 02 Feb 2016
Thrombectomy did not improve outcomes for myocardial infarct (MI) patients presenting after symptom onset, according to a new study. More...


Researchers at University College London (UCL; United Kingdom), the University of Manchester (United Kingdom), and other institutions conducted a retrospective study based on a UK national registry to examine thrombectomy use in ST-segment elevation MI (STEMI) patients and relationship to overall mortality. In all, 98,176 patients treated via percutaneous coronary intervention (PCI) were grouped on the basis of whether they received thrombectomy or not; subgroups of simple (manual aspiration) and complex (mechanical) thrombectomy were also evaluated.

The results showed no significant mortality difference between the overall thrombectomy group and the no thrombectomy group, either at 30 days or at one year. Likewise, no difference was seen between the simple thrombectomy versus no thrombectomy. The complex thrombectomy group, on the other hand, demonstrated significantly higher mortality at one-year follow-up. The researchers observed that thrombectomy use markedly increased in the United Kingdom between 2008 and 2010, but plateaued thereafter at slightly below 50% of all primary PCI cases. The study was published in the January 2016 issue of JACC: Cardiovascular Interventions.

“Our large observational study does not provide evidence to support the hypothesis that selective thrombectomy in primary PCI is associated with lower mortality,” concluded lead author Alex Sirker, MB BChir, and colleagues. “Our findings are in keeping with other negative clinical outcomes from two recent large randomized controlled trials studying routine thrombectomy use in STEMI.”

“Thrombus removal remains an intuitively valid concept; however, thrombus removal is more complex than initially appreciated,” added Dharam Kumbhani, MD, of the University of Texas Southwestern Medical Center (Dallas, USA) and Anthony Bavry, MD, of the University of Florida, (Gainesville, USA), in a related editorial. “Future studies will need to similarly rigorously evaluate the role of selective thrombectomy versus no thrombectomy, determine more effective thrombectomy devices, and better discriminate appropriate lesions to which this therapy can be applied.”

Thrombectomy with aspiration of thrombus prior to PCI is thought to prevent distal embolization and improve microvascular perfusion. But although electrocardiographic and angiographic outcomes improve with thrombectomy, such as an increased ST-segment resolution and a decreased distal embolization, no clinical benefits have been shown. One recent large study even found that the risk of stroke actually increased by 66%.

Related Links:

University College London
University of Manchester



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.